Login

CoViD-19: Inflammation and Molecular Imaging

20–23 May 2021
Remote
Europe/Rome timezone

Contribution List

42 out of 42 displayed
Export to PDF
  1. 11. Opening - Welcome Speeches
    Franco Garibaldi (Istituto Nazionale di Fisica Nucleare)
    20/05/2021, 15:00

    Organizers (10 min)
    Organizing Institutes Representatives (5 min + 5 min)

    Go to contribution page
  2. 101. COVID-19 in 2021: Lessons Learned and Remaining Challenges
    Anthony S. Fauci (Director of the National Institute of Allergy and Infectious Diseases, NIH/USA)
    20/05/2021, 15:20

    Registered talk courtesy provided by Accademia Nazionale del Lincei and Ospedale Pediatrico Bambino Gesù

    Go to contribution page
  3. 51. Origin and evolution of SARS-CoV-2
    Elisa Vicenzi (San Raffaele – Milano)
    20/05/2021, 15:40
  4. 47. Vaccines and monoclonals to regain our freedom
    Rino Rappuoli (GSK Vaccines and MAD Lab (TLS))
    20/05/2021, 16:00
  5. 52. COVID-19: A System disease
    Prof. Alessandra Bandera (University of Milan)
    20/05/2021, 16:45
  6. 53. Immunology
    Prof. Maria Rescigno (University of Humanitas)
    20/05/2021, 17:05
  7. 8. Mathematics and data science of Covid
    Giorgio Parisi (President Accademia dei Lincei)
    20/05/2021, 17:25
  8. 105. Multimodal X-ray Imaging with Darkfield Contrast: Improved COVID-19 Detection with Chest X-rays
    Prof. Franz Pfeiffer (Technical University Munich)
    20/05/2021, 18:00

    Diseases of the respiratory system are leading global causes of chronic morbidity and mortality. While advanced medical imaging technologies of today deliver detailed diagnostic information, a low-dose, fast, and inexpensive option for early detection and/or follow-ups is still lacking.
    Here, we report on the first human application of a novel modality, namely X-ray dark-field chest imaging,...

    Go to contribution page
  9. 59. Medium effects of COVID-19 on multi-system health focusing on the potential role of inflammation
    Betty Raman (Centre for Clinical Magnetic Resonance Research, Oxford)
    20/05/2021, 18:20
  10. 42. Rapid diagnosis of patients with COVID-19 by Artificial Intelligence
    Yang Yang (Radiology – Mount Sinai, NY/USA)
    20/05/2021, 18:40

    https://www.nature.com/articles/s41591-020-0931-3

    Go to contribution page
  11. 61. Understanding the radiation risks associated with molecular imaging
    Michael K. O'Connor (Mayo Clinic, Section of Nuclear Medicine, Rochester)
    21/05/2021, 15:00
  12. 62. Role of 2-[18F]FDG as a Radiopharmaceutical for PET/CT in patients with COVID-19
    Arturo Chiti (Humanitas University – Milan – Italy)
    21/05/2021, 15:20
  13. 18. What molecular imaging of cancer patients can teach us about COVID-19
    Silvana Del Vecchio (Nuclear Medicine, Department of Advanced Biomedical Sciences, University Federico II)
    21/05/2021, 15:40
  14. 20. 18F-FDG brain PET hypometabolism in post-SARS-CoV-2 infection: substrate for persistent/delayed disorders?
    Prof. E. Guedj (Nuclear Medicine, Univ. Marseille)
    21/05/2021, 16:15
  15. 29. The role for dynamic imaging
    Irène Buvat (Curie Institute – Orsay)
    21/05/2021, 16:35
  16. 89. The case for the Total Body PET imaging of CD8+ T Cells for researching COVID-19
    Terry Jones (University of California Davis)
    21/05/2021, 17:05
  17. 66. Imaging Immune phenomena
    Martin Pomper (Johns Hopkins – Baltimore)
    21/05/2021, 17:25
  18. 30. Potential Role of Conventional and Total Body PET Imaging in Assessing Systemic Complications of COVID Infection
    Abass Alavi (Penn Medicine, University of Pennsylvania)
    21/05/2021, 17:45
  19. 81. The potential role of AI in NM imaging
    Dimitris Visvikis (INSERM)
    21/05/2021, 18:20
  20. 97. The potential of the EuPRAXIA photon beams for CoViD-19 research
    Francesco Stellato (ROMA2)
    21/05/2021, 18:40

    The advent of Free Electron Lasers (FELs) opened up the way for an unprecedented, wide class of experiments exploiting the peculiar features of these radiation sources. Key elements of FEL beams are the high peak brilliance, the short pulse duration, which is of the order of tens of femtoseconds, and the high degree of coherence of the radiation.
    EuPRAXIA is the first European project that...

    Go to contribution page
  21. 104. Zn-induced interactions between SARS-CoV-2 orf7a and BST2/tetherin
    Silvia Morante (ROMA2)
    21/05/2021, 19:00

    In this talk I will present a first X-ray Absorption Spectroscopy study of the interactions of Zn with human BST2/tetherin and SARS- CoV-2 orf7a proteins as well as with some of their complexes. The analysis of the XANES region of the measured spectra shows that Zn can bind to BST2, as well as to orf7a and that BST2-orf7a complexes get formed. These structural information confirm the...

    Go to contribution page
  22. 19. Advances in PET/CT imaging with Biograph Vision and Quadra
    Maurizio Conti (Siemens – Healthineers Molecular Imaging)
    22/05/2021, 15:00
  23. 33. On the way to the 10 ps TOF-PET challenge
    Paul Lecoq (CERN)
    22/05/2021, 15:20

    https://the10ps-challenge.org

    Go to contribution page
  24. 71. Total body - PET imaging from the top of the head to the toes?
    Terry Jones (University of California Davis)
    22/05/2021, 15:40
  25. 72. Clinical applications of Total Body PET
    Hongcheng Shi (Nuclear Medicine Fudan University)
    22/05/2021, 16:15
  26. 73. Alternative applications of Total Body PET
    Stefaan Vandenberghe (MEDISIP-IBBT-Ugent)
    22/05/2021, 16:35
  27. 90. PET/Compton Hybrid as the Imager of the next generation
    Gabriela Llosa (Instituto de Física Corpuscular (IFIC/CSIC-UVEG))
    22/05/2021, 16:55
  28. 74. Therapy for Early COVID-19 - A Critical Need
    Arzhang Cyrus Javan (NIH – DAIDS)
    22/05/2021, 17:30
    Talk
    Therapy
  29. 91. The role of nuclear medicine in therapy evaluation of infectious diseases
    Martina Sollini (Humanitas University – Milan – Italy)
    22/05/2021, 17:50
    Talk
    Therapy
  30. 36. INFN and Catania Univ. Anti Covid Lab for face mask characterisation
    Giacomo Cuttone (LNS)
    22/05/2021, 18:20
  31. 95. Spike Proteins in MERS-CoV, SARS-CoV and SARS-CoV-2 Coronaviruses: Differences in Proteic Conformation
    Dr Annalisa D'Arco (Istituto Nazionale di Fisica Nucleare and SBAI Department, Sapienza University of Rome)
    22/05/2021, 18:40

    In recent years, three different coronaviruses (MERS-CoV, SARS-CoV and SARS-CoV-2), posed a grave threat to the global public health, security and economy. All these RNA viruses present a similar surface structure characterized by Spike Glycoproteins (S) having a key role in viral pathogenesis. The S proteins protrude from the surface of mature virion (see Fig. 1), and are responsible for...

    Go to contribution page
  32. 103. On Resonant Ablation of CoViD Virus in Public Places
    Yogendra Srivastava (PG)
    22/05/2021, 19:00

    According to the latest US CDC declarations, Covid infection is largely transmitted by air and not -as previously supposed- by touching objects “polluted” by others. Thus, at least in public gatherings, we should focus more on cleaning the air surrounding participants rather than on disinfecting objects in contact with them. A low-cost method to accomplish it consists in beaming signals at...

    Go to contribution page
  33. 38. Accurate Image Quantification with Advanced Image Reconstruction
    Harry Tsoumpas (University of Leeds)
    23/05/2021, 15:00
  34. 96. Automatic Lung Analysis for COVID-19 Patients
    Dr Fei Gao (Siemens Healthineers)
    23/05/2021, 15:20

    Objectives: Coronavirus disease 2019 (COVID-19) is an infectious lung disease affecting more than 124 million individuals worldwide as of Mar 28, 2021, and still significantly impacts our daily life. In 2020, we presented an automatic lung analysis workflow to analyze lung function quantitatively at the lung lobe level [1]. To further support and contribute to COVID-19 analysis, we...

    Go to contribution page
  35. 102. The role of AI in COVID-19 management: quantification of lung involvement using CT scans
    Francesca Lizzi (Istituto Nazionale di Fisica Nucleare)
    23/05/2021, 15:40

    Purpose: The World Health Organization (WHO) fixed as the gold standard for COVID-19 diagnosis the positive tested RT-PCR while the use of Computed Tomography (CT) images and Artificial Intelligence (AI) for this purpose is still under evaluation since differential diagnosis for other kinds of pneumonia is not reliable. However, AI and CT may be useful to follow up patients and to evaluate...

    Go to contribution page
  36. 92. Artificial intelligence to reduce the radiation burden for PET/CT imaging of COVID patients
    Kuangyu Shi (University of Bern)
    23/05/2021, 16:15
  37. 85. COVID-19 therapy optimization by AI-driven biomechanical simulations
    Cecilia Voena (ROMA1)
    23/05/2021, 16:35

    Prognostic methods to predict the evolution of the COVID-19 disease can be decisive to address the most suitable therapeutic approach. We propose an AI algorithm to make predictions of the patient respiratory condition and functional response, by merging information from CT scans, blood gas analysis and biomechanical simulations of air ventilation in the lung tissues performed by the software...

    Go to contribution page
  38. 98. The point of view of the Regulatory Agency
    Dr Marco Cavaleri (EMA)
    23/05/2021, 17:05
  39. 35. From fundamental physics research to medical applications: Ventilation System and PET
    Art McDonald (Queen's University, Kingston, Canada)
    23/05/2021, 17:25
  40. 93. Lessons from the COVID-19 Pandemic - Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of (Europe’s) Public Health Systems
    Giuseppe Ippolito (Spallanzani Institute – Scientific Director)
    23/05/2021, 17:45
  41. 50. The role of media in a pandemy
    Maurizio Molinari (Director "La Repubblica" Newspaper)
    23/05/2021, 18:05
  42. 106. Round Table
    Andrea Gori (Policlinico of Milan), Arturo Chiti (Humanitas University – Milan – Italy), Giorgio Parisi (ROMA1), Giuseppe Ippolito (Spallanzani Institute – Scientific Director), Dr Marco Cavaleri (EMA), Maurizio Molinari (Director "La Repubblica" Newspaper), Paul Lecoq (CERN)
    23/05/2021, 18:25